Clinical

Clinical, Original Research

Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs for Patients with Newly Diagnosed Systolic versus Diastolic Heart Failure

Chi Nguyen, PhD; Xian Zhang, PhD; Thomas Evers, PhD; Vincent J. Willey, PharmD; Hiangkiat Tan, MS, BPharm; Thomas P. Power, MD, FACC, MRCPI

Clinical, Original Research

A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making

Madison M. Wempe, BS; Mark D. Stewart, PhD; Daniel Glass, PhD; Laura Lasiter, PhD; Diana Merino Vega, PhD; Nisha Ramamurthy; Jeff Allen, PhD; Ellen V. Sigal, PhD

Stakeholder Perspective

Navigating the Complex World of Diagnostic Tests and Their Role in Clinical Decision-Making

James T. Kenney, RPh, MBA

Clinical, Original Research

Mental Health Conditions and Hospitalizations for Ambulatory Care Sensitive Conditions Among Veterans with Diabetes

Drew A. Helmer, MD, MS; Nilanjana Dwibedi, BPharm, MBA, PhD; Mazhgan Rowneki, MPH; Chin-Lin Tseng, DrPH; Dennis Fried, PhD; Danielle Rose, PhD; Nisha Jani, MPH, PhD; Usha Sambamoorthi, PhD

Stakeholder Perspective

Mental Health Conditions Constitute Significant Comorbidity: The Impact on Potentially Avoidable Hospital Admissions

Gary M. Owens, MD

Clinical, Original Research

Medication Use Before and After Hospitalization for Chronic Obstructive Pulmonary Disease in a Cohort of Elderly Patients with a Medicare Advantage Plan

Qingqing Xu, MS; Sarah S. Laxa, PharmD; Omar Serna, PharmD, BCACP; Sujit S. Sansgiry, MS, PhD

Stakeholder Perspective

Improving Medication Use for Chronic Diseases by Reducing Costs, Increasing Patient Adherence

F. Randy Vogenberg, PhD, FASHP

Clinical, Original Research

Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis

Rajeshwari Punekar, MPH, PhD; Jeannie Choi, PharmD; Susan Boklage, MS, MPH; Melitza Iglesias- Rodriguez, MD; Kamala Nola, PharmD, MS

Clinical, Original Article

Employer-Sponsored Wellness Programs for Hypertension and Dyslipidemia in a 2-Hospital Health System

Anne Misher, PharmD, BCACP, BC-ADM, CDE; Jessica Brown, PharmD; Christina Maguire, PharmD; Alix P. Schnibben, PharmD, BCACP, CTTS

Stakeholder Perspective

Benefits of Employer-Sponsored Wellness Programs for Chronic Diseases

F. Randy Vogenberg, RPh, PhD, FASHP

Clinical, Original Research

Dipeptidyl Peptidase-4 Inhibitors and Joint Pain: A Retrospective Cohort Study of Older Veterans with Type 2 Diabetes Mellitus

Pragya Rai, MS; Nilanjana Dwibedi, PhD; Mazhgan Rowneki, MPH; Drew A. Helmer, MD, MS; Usha Sambamoorthi, PhD

Stakeholder Perspective

Impact of DPP-4 Inhibitors on Joint Pain in Older Veterans with Diabetes

Priya Nileshwar, DO; Quang Nguyen, DO, FACE, FTOS

Clinical, Original Research

Charlson Comorbidity Index: ICD-9 Update and ICD-10 Translation

William P. Glasheen, PhD; Tristan Cordier, MPH; Rajiv Gumpina, MS; Gil Haugh, MS; Jared Davis, MD, MBA; Andrew Renda, MD, MPH

Clinical, Original Research

Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults

Aisha Vadhariya, PhD Candidate; Marc L. Fleming, PhD, MPH, RPh; Michael L. Johnson, PhD; E. James Essien, MD, DrPH; Omar Serna, PharmD, BCACP; Tara Esse, PharmD, BCACP; Jeannie Choi, PharmD; Susan H. Boklage, MS, MPH; Susan M. Abughosh, PhD

Clinical, Original Research

Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database Analysis

Jeffrey T. Guptill, MD, MA, MHS; M. Chris Runken, PharmD; Michael Eaddy, PharmD, PhD; Orsolya Lunacsek, PhD; Rupali M. Fuldeore, MS

Stakeholder Perspective

Enhanced Understanding and Management of Rare Diseases Can Reduce Costs, Improve Clinical Outcomes

James T. Kenney, RPh, MBA

Page 1 of 14
Results 1 - 10 of 133